Cargando…
Compensatory Mechanisms in Early Alzheimer’s Disease and Clinical Setting: The Need for Novel Neuropsychological Strategies
Despite advances in the detection of biomarkers and in the design of drugs that can slow the progression of Alzheimer’s disease (AD), the underlying primary mechanisms have not been elucidated. The diagnosis of AD has notably improved with the development of neuroimaging techniques and cerebrospinal...
Autores principales: | Torrealba, Eduardo, Aguilar-Zerpa, Norka, Garcia-Morales, Pilar, Díaz, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259077/ https://www.ncbi.nlm.nih.gov/pubmed/37313485 http://dx.doi.org/10.3233/ADR-220116 |
Ejemplares similares
-
Neuronal ER-Signalosome Proteins as Early Biomarkers in Prodromal Alzheimer's Disease Independent of Amyloid-β Production and Tau Phosphorylation
por: Mesa-Herrera, Fátima, et al.
Publicado: (2022) -
The brain compensatory mechanisms and Alzheimer's disease progression: a new protective strategy
por: Bobkova, Natalia, et al.
Publicado: (2015) -
Differences between Early and Late-Onset Alzheimer’s Disease in Neuropsychological Tests
por: Sá, Francisca, et al.
Publicado: (2012) -
The Neuropsychological Characteristics in Early Stage of Alzheimer's Patients with Depression
por: Yang, YoungSoon, et al.
Publicado: (2016) -
In-Out-Test: A New Paradigm for Sorting the Wheat from the Chaff in Prodromal Alzheimer’s Disease
por: Torrealba, Eduardo, et al.
Publicado: (2019)